FinTechFunding

Mayne Pharma: Appoints former AstraZeneca leader as new CEO

Mayne Pharma Appoints former AstraZeneca leader as new CEO

  • Mayne Pharma (MYX) appoints Shawn Patrick O’Brien as its new CEO and Managing Director
  • Following the retirement of Scott Richards, announced last month, Mr O’Brien will take the reigns on October 1
  • MYX says with over 35 years of experience in the global pharmaceutical industry, including 17 years at AstraZeneca, the new CEO is an “ideal choice” to lead the company
  • The company says Mr O’Brien has “a proven ability” to turn around organisations, lead large and diverse teams, and deliver growth within both public and private companies
  • MYX shares are up 4.9 per cent trading at 27 cents at 1:36 pm AEST
Previous article
Checkmate: Lands $5m seed funding
Next article
Spacetalk: Officially launches JumpySIM in Australia
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NYSE Parent Invests $600M in Polymarket, Strengthening Market Position

This significant investment signals confidence in the future of predictive markets.Highlights: NYSE's parent company allocates $600M to Polymarket.Investment...
FinTech

Nexi Expands SEPA Direct Debit with Danish Banks, Enhancing Payments Integration

Nexi's collaboration with Danish banks aims to strengthen payment services across Europe.Highlights: Nexi partners with several Danish banks...
FinTech

Lloyds Confirms App Glitch Exposed Data of Almost Half a Million Customers

The significant data breach prompts concerns over customer privacy.Highlights: Lloyds Banking Group admits to a data breach affecting...
FinTech

Mastercard Restricts Sale of Nets Payments Unit Purchased for $3.2 Billion

Mastercard looks to divest its Nets payments segment as part of strategic realignment.Highlights: Mastercard is seeking to sell...